Skip to main content

Tweets

The ultimate treatment goal in LN is long term preservation of kidney function. Summary of part 3 of @andreafava brilliant talk. #RNL2024 @RheumNow https://t.co/vwiAbWEmRh
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Very insightful talk on Vasculitis and pregnancy by Catherine Sims. Pregnancy compatible medications. Remission state. Checking antibodies ; risk of transmission, pregnancy and fetal morbidity. #RNL2024 @RheumNow https://t.co/81NAN1ulO5
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
#RNL2024 @RheumNow @JointMD on AxSpA SPEED study: roughly 1/2 AS have AxSpA, 1/2 have nr-AxSpA Are they similar: - Yes, but r-axSpA less F and more abnml CRP = Low progression of nr-AxSpA to AS - only 26% progressed in mean 10.6 yrs https://t.co/Vwf5HaMcgu
Eric Dein @ericdeinmd ( View Tweet )
2 years ago
We all want to preserve kidney function in lupus nephritis and to have good none invasive method to do that is just great. Low IL-16 at 12 months predicted kidney survival at 3 years better than proteinuria. 👏 @andreafava and his team. #RNL2024 @RheumNow https://t.co/O0trWoAqZz
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Urine biomarkers ( IL-16, CD163,CD206), parallel internal activity in lupus nephritis and and its decline at 3 months , best predict 1 year response . Future is great for lupus nephritis , cant wait to start using them. Great work @andreafava #RNL2024 @RheumNow https://t.co/VIFMytHFyD
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Urine proteomics in lupus nephritis. Summary of part one of his amazing talk. @andreafava #RNL2024 @RheumNow https://t.co/h8Eda0ZWVE
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Neutrophil signature in proliferative lupus nephritis. @andreafava #RNL2024 @RheumNow https://t.co/tNFIhohSvP
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Cancer and Myositis #RNL2024 @RheumNow @DrLisaCS on Cancer screening: Risk stratify: dermatomyositis, NXP2, TIFy, <40yo, refractory, dysphagia, cutaneous necrosis at higher risk Enhanced risk stratification for those at risks, versus "basic screening" for lower risks https://t.co/3yy9Fx1pk8
Eric Dein @ericdeinmd ( View Tweet )
2 years ago
Dr Christopher-Stine @DrLisaCS Factors which should influence (some very strongly) your cancer screening approach in myositis @RheumNow #RNL2024 https://t.co/BoyJLrVDwo
Richard Conway @RichardPAConway ( View Tweet )
2 years ago
anti-Sp4 Ab may be protective against cancer in myositis pts who are TIF1-g positive - Dr. L Christopher-Stine #RNL2024 @rheumnow https://t.co/n7Ikn3llGH
TheDaoIndex @KDAO2011 ( View Tweet )
2 years ago
Continue to love this myositis diagram. Seems to be getting ever more complicated though! @DrLisaCS @RheumNow #RNL2024 https://t.co/eXz6144y3y
Richard Conway @RichardPAConway ( View Tweet )
2 years ago
Cancer and Myositis #RNL2024 @RheumNow @DrLisaCS Dermatomyositis risks - TIF1y is highest risk, followed by NXP2 Protective features: childhood onset, ILD, arthralgias Cancer and myositis often present w/in 1 yr before or after Cancer is major cause of death

Eric Dein @ericdeinmd ( View Tweet )

2 years ago
×